Targeting VEGF with bevacizumab inhibits malignant effusion formation of primary human herpesvirus 8‐unrelated effusion large B‐cell lymphoma in vivo

Primary human herpesvirus 8 (HHV8)‐unrelated effusion large B‐cell lymphoma (ELBCL) is recognized as a new clinical entity, but its pathogenesis and therapeutic strategies remain largely unknown. We have generated two mouse models with profuse lymphomatous effusions that resemble HHV8‐unrelated ELBC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogasawara, Fumiya, Higuchi, Tomonori, Nishimori, Tomohiro, Hashida, Yumiko, Kojima, Kensuke, Daibata, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667516/
https://www.ncbi.nlm.nih.gov/pubmed/36209502
http://dx.doi.org/10.1111/jcmm.17570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667516/
https://www.ncbi.nlm.nih.gov/pubmed/36209502
http://dx.doi.org/10.1111/jcmm.17570

Ejemplares similares